aspect
of
doctor)
→
CapableOf
→
receive glyburide
Typicality: | 0.574 |
Saliency: | 0.379 |
with bosentan | 3 | other |
concomitantly | 2 | manner |
in double-blind clinical studies | 2 | location |
patient → receive → glyburide | 17 |
patient → be treated with → glyburide | 6 |
patient → take → glyburide | 3 |
negative | neutral | positive |
0.357 | 0.612 | 0.031 |
Raw frequency | 26 |
Normalized frequency | 0.379 |
Modifier score | 1.000 |
Perplexity | 134.499 |